HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiki Ohnuki Selected Research

Hypertrophy of Masticatory Muscles

5/2016Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.
1/2015Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
12/2014Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation.
1/2013Effects of chronic Akt/mTOR inhibition by rapamycin on mechanical overload-induced hypertrophy and myosin heavy chain transition in masseter muscle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiki Ohnuki Research Topics

Disease

5Fibrosis (Cirrhosis)
02/2022 - 01/2019
5Bites and Stings (Sting)
01/2019 - 06/2005
5Hypertrophy
01/2019 - 01/2013
4Heart Failure
12/2021 - 03/2015
4Hypertrophy of Masticatory Muscles
05/2016 - 01/2013
2Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 12/2021
2Septic Shock (Toxic Shock Syndrome)
01/2018 - 01/2017
2Muscular Atrophy (Muscle Atrophy)
05/2016 - 01/2015
2Cardiomyopathies (Cardiomyopathy)
06/2014 - 02/2008
1Periodontitis
12/2021
1Atrial Remodeling
01/2020
1Endotoxemia
01/2018
1Obesity
01/2016
1Atrophy
01/2015
1Cardiomegaly (Heart Hypertrophy)
12/2014
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
02/2008
1Body Weight (Weight, Body)
06/2005

Drug/Important Bio-Agent (IBA)

6Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2015 - 06/2005
5Calcium-Calmodulin-Dependent Protein KinasesIBA
12/2021 - 12/2014
4ClenbuterolIBA
05/2016 - 09/2013
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
12/2021 - 12/2014
3erythromycin propionate-N-acetylcysteinateIBA
01/2018 - 12/2014
3Proteins (Proteins, Gene)FDA Link
05/2016 - 02/2008
3Protein Isoforms (Isoforms)IBA
01/2015 - 01/2013
2Adrenergic Agents (Adrenergic Drugs)IBA
02/2022 - 09/2013
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2019
2Serine (L-Serine)FDA Link
01/2020 - 12/2014
2TOR Serine-Threonine KinasesIBA
01/2019 - 01/2013
2CytokinesIBA
01/2018 - 01/2017
2CatecholaminesIBA
01/2018 - 01/2017
2Histone Deacetylases (Histone Deacetylase)IBA
05/2016 - 12/2014
2Cyclic AMP (AMP, Cyclic)IBA
05/2016 - 12/2014
2Adrenergic Receptors (Adrenergic Receptor)IBA
03/2015 - 09/2013
2Isoproterenol (Isoprenaline)FDA LinkGeneric
12/2014 - 06/2014
2CalcineurinIBA
01/2013 - 06/2005
1Vidarabine (Vira-A)FDA Link
02/2022
1Propranolol (Inderal)FDA LinkGeneric
01/2020
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2019
1Polymethyl Methacrylate (Sol)IBA
05/2016
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
03/2015
1GlucocorticoidsIBA
01/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2015
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2014
1Sirolimus (Rapamycin)FDA Link
01/2013
1Troponin IIBA
02/2008
1myosin-binding protein CIBA
02/2008
1Trinitrotoluene (TNT)IBA
02/2008
1myosin light chain 2IBA
02/2008
1Troponin T (Troponin T1)IBA
02/2008
1Adenosine Triphosphatases (ATPase)IBA
02/2008
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2005
1Messenger RNA (mRNA)IBA
06/2005

Therapy/Procedure

2Vertical Dimension (Occlusion Vertical Dimension)
08/2009 - 06/2005
1Therapeutics
01/2016
1Drug Therapy (Chemotherapy)
01/2015